Neural Cell News 11.19 May 17, 2017 | |
| |
TOP STORYSpinal Muscular Atrophy: New Clues to Cause and Treatment Spinal muscular atrophy (SMA), a neurodegenerative disease that causes progressive muscle wasting and paralysis, may be partly due to abnormalities in the synapses that connect sensory neurons and motor neurons, according to researchers at Columbia University Medical Center. Their study, conducted in mice, also showed that increasing the activity of these synapses alone can alleviate symptoms of SMA. [Press release from Columbia University Medical Center discussing online prepublication in Nature Neuroscience] Press Release | Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Investigators report a novel chromatin-associated function of phosphatase and tensin homolog (PTEN) in complex with the histone chaperone DAXX and the histone variant H3.3. They showed that PTEN interacts with DAXX and, in turn PTEN directly regulates oncogene expression by modulating DAXX-H3.3 association on the chromatin, independently of PTEN enzymatic activity. [Nat Commun] Full Article Combined HMG-CoA Reductase and Prenylation Inhibition in Treatment of CCM The authors performed a high-throughput screen to identify Food and Drug Administration-approved drugs or other bioactive compounds that could effectively suppress hyperproliferation of mouse brain primary astrocytes deficient for cerebral cavernous malformations (CCMs). They demonstrated that fluvastatin, an inhibitor of 3-hydroxy-3-methyl-glutaryl-CoA reductase and the N-bisphosphonate zoledronic acid monohydrate, an inhibitor of protein prenylation, act synergistically to reverse outcomes of CCM3 loss in cultured mouse primary astrocytes and in Drosophila glial cells in vivo. [Proc Natl Acad Sci USA] Full Article Voltage-Gated Na+ Currents in Human Dorsal Root Ganglion Neurons Scientists determined the extent to which the biophysical and pharmacological properties of voltage-gated Na+ channels were comparable in rat and human sensory neurons. Their results indicated that while the two major current types, generally referred to as tetrodotoxin (TTX)-sensitive and TTX-resistant were qualitatively similar in neurons from rats and humans, there were several differences that have important implications for drug development as well as the understanding of pain mechanisms. [Elife] Full Article Dovitinib Enhances Temozolomide Efficacy in Glioblastoma Cells Researchers used glioblastoma (GB) patient cells and cell lines to show that Dovitinib (Dov) downregulated the stem cell protein Lin28 and its target high mobility group protein A2 (HMGA2). The Dov-induced reduction in pSTAT3Tyr705 phosphorylation demonstrated that Dov negatively affects the STAT3-LIN28-Let-7-HMGA2 regulatory axis in GB cells. [Mol Oncol] Full Article Investigators found that ZBP1 is phosphorylated at Ser181 in neurons in a mammalian/mechanistic target of rapamycin complex 2-, Src kinase-, and mRNA binding-dependent manner. They found that Ser181 ZBP1 phosphorylation was essential for the proper dendritic branching of hippocampal neurons that were cultured in vitro and for the proper ZBP1 dendritic distribution and motility. [Sci Rep] Full Article Differentiation of Human Olfactory Bulb-Derived Neural Stem Cell towards Oligodendrocyte Development Scientists differentiated human olfactory bulb neural stem cells (OBNSCs) into oligodendrocyte precursor cells/oligodendrocytes (OPCs/OLs), and using expression profiling gene, immunocytochemistry and specific protein expression, they highlighted the molecular mechanism(s) underlying differentiation of human OBNSCs into OPCs/OLs. [J Cell Physiol] Abstract The authors investigated the implication of vesicular glutamate transporters (VGLUTs) in the differentiation of subventricular zone (SVZ)-derived neural precursor cells (NPCs). Their results showed that NPCs express VGLUT1-3 and excitatory amino acid transporters 1-3 both at the mRNA and protein level. Their expression increases during differentiation closely associated with the expression of marker genes. [PLoS One] Full Article Researchers investigated the effect of various concentrations and ratios of linoleic acid (LA) and alpha linolenic acid (ALA), which belong respectively to omega-6 and omega-3 polyunsaturated fatty acids, on the proliferation and differentiation of embryonic neural stem cells. Results showed that low or high concentrations of ALA, but not LA, and the ratio of 1:3 of LA/ALA significantly increased neurospheres size, frequency and cell numbers, in comparison to controls. [Neurosci Lett] Abstract | |
| |
REVIEWSHuntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells The authors discuss the early molecular pathogenesis of Huntington disease (HD) in pluripotent and neural stem cells, with respect to the neurodevelopmental aspects of HD. [Mol Neurobiol] Full Article Alzheimer’s Disease, Dementia, and Stem Cell Therapy Investigators focus on recent advances in stem cell therapies utilizing animal models of Alzheimer’s disease (AD), as well as detailing the human clinical trials of stem cell therapies for AD that are currently undergoing development. [Stem Cell Res Ther] Full Article Visit our reviews page to see a complete list of reviews in the neural cell research field. | |
| |
INDUSTRY NEWSLCT Collaborates with Center for Brain Research to Extend Product Pipeline Living Cell Technologies Limited (LCT) has initiated a research collaboration with the Centre for Brain Research at the University of Auckland. The research collaboration will explore how LCT’s products can reverse human brain neurodegenerative processes associated with pericytes (and other brain cells), which help sustain the blood-brain barrier and other homeostatic and haemostatic functions in the brain. [Living Cell Technologies Limited] Press Release Enterin’s RASMET Study Enrolls First Patient with Parkinson’s Disease Enterin Inc. enrolled the first patient in the RASMET study. The study is a Phase I/IIa randomized, controlled, multicenter study involving patients with Parkinson’s disease and taking place at 12 US sites. The study will establish the safety, tolerability and efficacy of an orally administered synthetic derivative of squalamine, which is not absorbed into the blood stream. [Enterin Inc. (PR Newswire Association LLC.)] Press Release Biohaven’s Trigriluzole Receives Fast Track Designation from U.S. FDA Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) announced that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track Designation for Biohaven’s product candidate trigriluzole for the potential treatment of spinocerebellar ataxia. [Biohaven Pharmaceutical Holding Company Ltd.] Press Release | |
| |
POLICY NEWSChina’s Belt and Road Infrastructure Plan Also Includes Science China’s plan to make massive investments in land and sea links with global trading partners also includes a little noticed commitment to support science and engineering, including the creation of dozens of new laboratories. [ScienceInsider] Editorial Trump Officials Act to Tilt Federal Science Boards toward Industry Critics say that changes to advisory groups at the Environmental Protection Agency and Department of Interior could restrict or paralyze them. [Nature News] Editorial Biology Needs More Staff Scientists Most research institutions are essentially collections of independent laboratories, each run by principal investigators who head a team of trainees. This scheme has ancient roots and a track record of success. But it is not the only way to do science. Indeed, for much of modern biomedical research, the traditional organization has become limiting. [Nature News] Editorial Revamped ‘Anti-Science’ Education Bills in United States Find Success State and local legislatures in the United States are experimenting with new ways to target the topics taught in science classes, and it seems to be paying dividends. Florida’s legislature approved a bill that would enable residents to challenge what educators teach students. [Nature News] Editorial
| |
EVENTSNEW Mechanisms of Neurodegeneration Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Senior/Principle Research Associate – Cell and Molecular Biology (Editas Medicine) NEW Postdoctoral Fellow – Neuroendocrine Biology of Metabolism (The Scripps Research Institute) Research Fellow – Neuroscience and Behavioral Disorders (Duke-NUS Medical School) Postdoctoral Scientist – Cell Biology (Medical Research Council) Postdoctoral Position – Molecular Biology (KU Leuven) Postdoctoral Researcher – Neuroscience and Imaging (Howard Hughes Medical Institute) Director – BrainHub (Carnegie Mellon University) Postdoctoral Position(s) – Visual Neuroscience (Yale University) Postdoctoral Fellow – Spinal Cord Injury Repair (Burke Medical Research Institute Cornell) Assistant/Associate Professor – Canada Research Chair in Mental Health (University of Alberta) Postdoctoral Researcher – Stem Cell Differentiation (University of Oklahoma) Neuroscientist – Precision Neurotherapeutics (University of California Davis) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Neural Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Neural Cell News Volume 11.19 | May 17 2017